I'm sorry to hear that, but in that the company is
Post# of 15624
(Total Views: 168)
Posted On: 03/31/2017 2:01:21 PM
I'm sorry to hear that, but in that the company is emerging as a force in their niche of being a cannabis based biotech, perhaps they'll begin doing webcasts at least annually, but preferably quarterly.
I recognize it's a little tougher doing it from Israel, because of the time difference, but if they are to build relationships with Institutions and Analysts, I believe they need the opportunity that such webcasts create to not only speak to them, but also take their questions in an open forum which eliminates the thought that they're getting inside information.
I'm a big believer that OWCP is trying to do business in a professional way. While I believe that they can legitimately tell us something more about the various trials they're running, they shouldn't give us all the details until they've been presented somewhere for peer review. I believe the Annual Report, and hopefully the webcast, will tell us more, but certainly nowhere near all the information that should be in what's presented for peer review.
For now, the greatest indication that all is well is the company's continued confidence that they'll be marketing product by the third quarter. I believe they may be overly optimistic about this, but even if it's delayed somewhat by restrictions caused by Govt. the fact is that it won't be that long before their products will be available for sale in some places in the world.
Gary
I recognize it's a little tougher doing it from Israel, because of the time difference, but if they are to build relationships with Institutions and Analysts, I believe they need the opportunity that such webcasts create to not only speak to them, but also take their questions in an open forum which eliminates the thought that they're getting inside information.
I'm a big believer that OWCP is trying to do business in a professional way. While I believe that they can legitimately tell us something more about the various trials they're running, they shouldn't give us all the details until they've been presented somewhere for peer review. I believe the Annual Report, and hopefully the webcast, will tell us more, but certainly nowhere near all the information that should be in what's presented for peer review.
For now, the greatest indication that all is well is the company's continued confidence that they'll be marketing product by the third quarter. I believe they may be overly optimistic about this, but even if it's delayed somewhat by restrictions caused by Govt. the fact is that it won't be that long before their products will be available for sale in some places in the world.
Gary
(0)
(0)